Today: 2 February 2026
Subscribe
Browse Category

EPA:AF News 3 January 2026 - 4 January 2026

Flights to Guyana disrupted after U.S. strikes Venezuela: Georgetown airport delays, KLM cancellations

Flights to Guyana disrupted after U.S. strikes Venezuela: Georgetown airport delays, KLM cancellations

GEORGETOWN, Guyana, January 3, 2026, 10:04 ET Flights at Guyana’s main international gateway in Georgetown were disrupted on Saturday, with cancellations and multi-hour delays showing up on airline and flight-tracking updates after U.S. strikes in neighboring Venezuela. The disruption matters now because Guyana sits on Venezuela’s eastern flank and has become a key entry point for business travel into the…
3 January 2026
·
Curaçao Flights Cancelled and Delayed After U.S. Strikes Venezuela, Airlines Issue Alerts

Curaçao Flights Cancelled and Delayed After U.S. Strikes Venezuela, Airlines Issue Alerts

WILLEMSTAD, Curacao, Jan 3, 2026, 09:59 ET KLM on Saturday canceled flights to Curaçao and several other Caribbean destinations after what it described as the closure of airspace around the island amid the fallout from U.S. strikes in Venezuela. The airline said the cancellations affected 2,600 passengers, and Schiphol Airport’s flight information page listed KLM flight KL733 to Curaçao as…
3 January 2026
··
Cancelled flights spike across Aruba after U.S. strikes Venezuela; Delta, United, JetBlue hit

Cancelled flights spike across Aruba after U.S. strikes Venezuela; Delta, United, JetBlue hit

ORANJESTAD, Aruba, Jan 3, 2026, 09:18 ET Aruba Airport said all flights operated by Avianca, Delta Air Lines, JetBlue, LATAM, Southwest Airlines, United Airlines and WestJet were canceled on Saturday as the region reacted to U.S. strikes in Venezuela. The airport also listed additional cancellations including Air Century 620, Frontier 320, KLM 765 and Winair 805. The cancellations matter now…
3 January 2026
······

Stock Market Today

  • Cantor Fitzgerald Raises Price Target for Regeneron Pharmaceuticals (NASDAQ:REGN)
    February 2, 2026, 11:58 AM EST. Cantor Fitzgerald increased its price target on Regeneron Pharmaceuticals (NASDAQ:REGN) from $740 to $800, maintaining an "overweight" rating, signaling a potential 5% upside. Other brokerages also raised forecasts, with BMO Capital Markets at $850, Guggenheim at $865, and Evercore ISI at $875. Regeneron's shares rose 2.7% to $761.32 amid increased trading volume. The biotech giant posted strong Q4 results with EPS of $11.44 beating estimates, and revenues up 2.5% year-over-year to $3.88 billion. The company holds a solid balance sheet with low debt and robust margins. Market consensus rates the stock as a "Moderate Buy" with an average price target near $790, reflecting optimism about Regeneron's growth prospects.
Go toTop